Table 1.

Demographic and laboratory features of HCV‐positive patients positive for anti‐ENA and or ANA

	Age	Gender	RNA	Genotype	HCV	IFA	Pattern	Sm	Sm/RNP	RNP	SSA	SSB	Scl‐70	dsDNA	CentB	Major diagnosis
1	61	M	Pos	NP†	16.12	1:40	Cytoplasmic fiber pattern	1.1 Lowa			1.0 Low					Chronic HCV Hepatocellular Carcinoma
2	67	M	Pos	3	12.59	1:40	Homogenous		1.0 Low	3.4 Mod.				22 Low		Chronic kidney disease
3	65	M	Pos	NP	11.58	1:160	Speckled			3.8 Mod.						Chronic HCV
4	62	M	Pos	1a	13.02	Neg	N/A			1.0 Low						Chronic HCV
5	60	M	Pos	1a	14.51	Neg	N/A				1.0 Low					Chronic HCV
6	53	M	NP	NP	10.01	Neg	N/A				3.2 Mod.					Trauma/Vehicular
7	62	F	Neg	NP	2.22	1:80	Speckled cytoplasm				7.1 High					Hypertension
8	62	M	Pos	3	6.56	1:40	Cytoplasmic fiber pattern					3.8 Mod.				Chronic HCV Hepatocellular Carcinoma
9	65	M	NP	NP	2.32	Neg	N/A						1.6 Low	1.7 Low		Gall stones
10	17	F	NP	NP	1.1	1:80	Speckled						1.2 Low			Arthritis
11	51	F	Pos	1a	12.81	1:80	Cytoplasmic fiber pattern						5.3 High			Heart failure
12	53	M	Pos	3	12.1	1:40	Speckled							28 Low		Chronic HCV
13	28	F	Pos	1a	16.08	1:40	Homogenous							27 Low		Trauma/Vehicular
14	65	M	Neg	NP	13.61	1:160	Centromere with cytoplasmic fiber pattern								1.0 Low	Chronic kidney disease
15	58	M	Pos	1b	5.92	1:160	Speckled									Chronic HCV

NP, Not performed; N/A, Not applicable.

^aLow=Low Positive, Mod.=Moderate Positive, High=High Positive.